144 related articles for article (PubMed ID: 8538293)
1. [Possible effect of administration methods on pharmacological action. Study of cytostatic therapy in advanced cancer].
Larsson PA; Carlsson G; Gustavsson B; Glimelius B; Graf W
Lakartidningen; 1995 Dec; 92(50):4793-6. PubMed ID: 8538293
[No Abstract] [Full Text] [Related]
2. Systemic therapy of colorectal cancer.
Hansen RM
Wis Med J; 1988 May; 87(5):27-9. PubMed ID: 3291406
[No Abstract] [Full Text] [Related]
3. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
[No Abstract] [Full Text] [Related]
4. Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid.
Grem JL; Hoth DF; Hamilton JM; King SA; Leyland-Jones B
Cancer Treat Rep; 1987 Dec; 71(12):1249-64. PubMed ID: 3319136
[No Abstract] [Full Text] [Related]
5. Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
Natoli C; Scognamiglio MT; Martino MT; Irtelli L; De Tursi M; Cianchetti E; Mascitelli E; Tinari N; Iacobelli S
Anticancer Res; 2000; 20(2B):1253-6. PubMed ID: 10810430
[TBL] [Abstract][Full Text] [Related]
6. Systemic cytostatic drug therapy in liver cancer.
Glimelius B
Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
[No Abstract] [Full Text] [Related]
7. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
[No Abstract] [Full Text] [Related]
9. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
[No Abstract] [Full Text] [Related]
11. [A clinical study of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for liver metastases].
Ichihara T; Tenma K; Itoh M; Hibino M; Kikuchi I; Sasaki Y; Hosono Y; Nakamura M
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1143-5. PubMed ID: 12938270
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
13. Puzzles in the clinical pharmacokinetics of fluorouracil.
Desoize B; Bouche O; Berthiot G; Coninx P
Anticancer Res; 1998; 18(6B):4607-10. PubMed ID: 9891526
[TBL] [Abstract][Full Text] [Related]
14. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil and cytarabine--ineffective treatment in advanced colorectal carcinoma: a Southeastern Cancer Study Group Trial.
Eisenstaedt RS; Neilan BA; Bartolucci A
Cancer Treat Rep; 1987; 71(7-8):779-80. PubMed ID: 3300971
[No Abstract] [Full Text] [Related]
16. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of colorectal cancer.
Kemeny N; Saltz L; Cohen A
Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
[TBL] [Abstract][Full Text] [Related]
19. [Treatment with cytostatic agents should be considered in colorectal cancer. It improves prognosis and quality of life].
Larsson PA
Lakartidningen; 1999 May; 96(19):2314-6. PubMed ID: 10377671
[No Abstract] [Full Text] [Related]
20. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
